BRIEF published on 02/18/2025 at 07:35, 1 year ago Sensorion announces its participation in congresses in March 2025 Biotechnology Sensorion Hearing Therapies Medical Innovations Congress 2025
PRESS RELEASE published on 02/18/2025 at 07:30, 1 year ago Inside Information / Other news releases Sensorion announces participation in upcoming congresses in March to present on innovative biologics and manufacturing challenges for hearing loss disorders Sensorion Hearing Loss Biologics Congresses Manufacturing Challenges
BRIEF published on 02/12/2025 at 11:35, 1 year 1 month ago Sensorion to Participate in ARO 48th Annual Midwinter Meeting Sensorion Hearing Loss ARO Meeting GJB2-GT Therapy Biotech Conference
PRESS RELEASE published on 02/12/2025 at 11:30, 1 year 1 month ago Inside Information / Other news releases Sensorion announces participation in ARO 48th Annual Midwinter Meeting with focus on gene therapy for deafness. Details of presentations by Sensorion executives included Gene Therapy Sensorion ARO Meeting Deafness Sensorion Executives
BRIEF published on 12/27/2024 at 07:35, 1 year 2 months ago Sensorion Completes Enrollment for Audiogene Phase 1/2 Trial Gene Therapy Sensorion Hearing Loss SENS-501 Audiogene Trial
PRESS RELEASE published on 12/27/2024 at 07:30, 1 year 2 months ago Inside Information / Other news releases Sensorion completes enrollment of the first cohort in the Audiogene Phase 1/2 gene therapy clinical trial, targeting infants with hearing loss disorders Gene Therapy Clinical Trial Sensorion Hearing Loss Disorders Audiogene
BRIEF published on 12/18/2024 at 07:35, 1 year 2 months ago Sensorion Reports Positive Preliminary Results for SENS-501 Gene Therapy Clinical Trial SENS-501 Congenital Deafness Biotechnological Innovation
PRESS RELEASE published on 12/18/2024 at 07:30, 1 year 2 months ago Inside Information / Other news releases Sensorion reports positive safety data and behavioral changes in toddlers from the Audiogene Phase 1/2 Gene Therapy Clinical Trial. Plans KOL event in 2025 for further discussion Gene Therapy Clinical Trial Sensorion Hearing Loss Audiogene
BRIEF published on 11/06/2024 at 07:35, 1 year 4 months ago Sensorion to Join Key Investor Conferences in November 2024 Biotechnology Investor Conferences Sensorion Hearing Loss Therapies Gene Therapy Development
PRESS RELEASE published on 11/06/2024 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion to participate in upcoming investor conferences in November 2024, including Stifel Healthcare Conference and LifeSci Capital & Sofinnova Partners Summit Biotechnology Investor Conferences Clinical-stage Sensorion Hearing Loss Disorders
Published on 03/16/2026 at 22:30, 8 hours 16 minutes ago Core Silver Intersects High-Grade Copper-Molybdenum Veins up to 7.31% Cu & 1.01% Mo Confirming Large Porphyry System at Laverdiere
Published on 03/16/2026 at 22:00, 8 hours 46 minutes ago Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
Published on 03/16/2026 at 21:30, 9 hours 16 minutes ago Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Published on 03/16/2026 at 21:00, 9 hours 46 minutes ago Amdocs Brings AI-Accelerated Application Modernization to Enterprises with NVIDIA
Published on 03/17/2026 at 06:29, 17 minutes ago Medartis builds on momentum with 16% organic sales growth and core EBITDA margin exceeding 18%
Published on 03/17/2026 at 03:40, 3 hours 6 minutes ago SANY and OCHA Sign Partnership Agreement at HNPW 2026
Published on 03/17/2026 at 02:10, 4 hours 36 minutes ago Clawchain.ai Launches on Chromia to Support the Next Generation of AI Agent Systems
Published on 03/17/2026 at 00:00, 6 hours 46 minutes ago Cango Inc. Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
Published on 03/16/2026 at 23:07, 7 hours 39 minutes ago KION brings physical AI into live warehouse operations at GTC 2026 in San José, California
Published on 03/16/2026 at 18:00, 12 hours 46 minutes ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 12 hours 48 minutes ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 12 hours 49 minutes ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:35, 13 hours 11 minutes ago Disclosure of transactions in own shares from March 9 to March 13, 2026
